10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $525,649 | -29.3% | 12,743 | -4.3% | 0.00% | 0.0% |
| Q2 2023 | $743,230 | +137.5% | 13,310 | +137.3% | 0.00% | 0.0% |
| Q1 2023 | $312,926 | +75.9% | 5,609 | +14.9% | 0.00% | – |
| Q4 2022 | $177,936 | -52.6% | 4,883 | -62.9% | 0.00% | -100.0% |
| Q3 2022 | $375,000 | -42.9% | 13,172 | -9.2% | 0.00% | 0.0% |
| Q2 2022 | $657,000 | -11.1% | 14,502 | +49.3% | 0.00% | 0.0% |
| Q1 2022 | $739,000 | -28.7% | 9,711 | +39.6% | 0.00% | -50.0% |
| Q4 2021 | $1,037,000 | +26.3% | 6,958 | +23.4% | 0.00% | 0.0% |
| Q3 2021 | $821,000 | -20.1% | 5,640 | +7.6% | 0.00% | 0.0% |
| Q2 2021 | $1,027,000 | +23.6% | 5,243 | +14.2% | 0.00% | 0.0% |
| Q1 2021 | $831,000 | +2867.9% | 4,591 | +2195.5% | 0.00% | – |
| Q4 2020 | $28,000 | +12.0% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | +38.9% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $18,000 | +50.0% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $12,000 | -20.0% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $15,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |